1. Hepatocellular carcinoma recurrence rate in HCV infected patients treated with direct antiviral agents. A single center experience. Issue 1 (16th February 2017) Authors: Granata, R.; Di Costanzo, G.G.; Sanduzzi Zamparelli, M.; Guarino, M.; Cordone, G.; D'Adamo, G.; Tortora, R. Journal: Digestive and liver disease Issue: Volume 49:Issue 1(2017)Supplement Page Start: e45 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P.09.16: Disparate Access to New Antiviral Treatment Regimens Affects Quality of Life in HCV-Infected Patients. (15th March 2017) Authors: Rocco, A.; Angrisani, D.; Carbone, M.; Sgamato, C.; Sanduzzi Zamparelli, M.; Coccoli, P.; Compare, D.; Nardone, G. Journal: Digestive and liver disease Issue: Volume 49(2017)Supplement 2 Page Start: e194 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P.09.7: Mucosal GUT Microbiota Composition in Patients with HCV Infection, from Chronic Hepatitis to Hepatocellular Carcinoma. (15th March 2017) Authors: Sanduzzi Zamparelli, M.; D'Argenio, V.; Casaburi, G.; Precone, V.; Esposito, M.V.; Lovero, D.; Postiglione, I.; Fosso, B.; Compare, D.; Coccoli, P.; Rocco, A.; Saviano, S.; Pesole, G.; Di Costanzo, G.G.; Salvatore, F.; Nardone, G. Journal: Digestive and liver disease Issue: Volume 49(2017)Supplement 2 Page Start: e190 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗